Center of Biologics Evaluation and Research, U.S. Food and Drug Administration, United States of America.
Center of Biologics Evaluation and Research, U.S. Food and Drug Administration, United States of America.
Thromb Res. 2024 Jan;233:189-199. doi: 10.1016/j.thromres.2023.11.024. Epub 2023 Nov 23.
Growing evidence supports the importance of factor (F) XI activation for thrombosis and hemostasis as well as inflammation and complement systems. In this study, we evaluated the effect of activated FXI (FXIa) on the detection of factor deficiencies by global hemostasis assays of thrombin generation (TG), plasmin generation (PG), and clot formation and lysis (CFL).
An absorbance and fluorescence microplate assay was used to simultaneously observe TG, PG, and CFL in FV-, FVII-, FVIII-, and FIX-deficient plasmas supplemented with purified factors. Coagulation was initiated with tissue factor with or without FXIa in the presence of tissue plasminogen activator. Thrombin and plasmin peak heights (TPH and PPH), maximal clot density (MCD), times to clotting (CT), thrombin and plasmin peaks (TPT and PPT) and clot lysis (LyT) and a new parameter, clot lifetime (LiT), were evaluated.
TG/CFL were elevated by the FXIa at low FV (below 0.1 IU/mL), and at FVIII and FIX above 0.01 IU/mL. FXIa affected PG only at low FV and FVII. At high factor concentrations, FXIa reduced MCD. Thrombin and plasmin substrates had effect on CT, LyT, LiT and MCD parameters.
FXIa reveals new relationships between TG, PG and CFL parameters in factor deficiencies suggesting potential benefits for discrimination of bleeding phenotypes.
越来越多的证据支持因子(F)XI 激活在血栓形成和止血以及炎症和补体系统中的重要性。在这项研究中,我们评估了活化 FXI(FXIa)对凝血酶生成(TG)、纤溶酶生成(PG)和纤维蛋白形成和溶解(CFL)的全球止血检测中因子缺乏的影响。
使用吸光度和荧光微孔板测定法,同时观察 FV-、FVII-、FVIII-和 FIX-缺陷血浆中 TG、PG 和 CFL 的变化,并用纯化因子补充。凝血通过组织因子启动,有或没有 FXIa 存在组织纤溶酶原激活物。凝血酶和纤溶酶峰高度(TPH 和 PPH)、最大纤维蛋白密度(MCD)、凝血时间(CT)、凝血酶和纤溶酶峰时间(TPT 和 PPT)和纤维蛋白溶解(LyT)以及一个新参数纤维蛋白溶解寿命(LiT)进行评估。
在低 FV(低于 0.1 IU/mL)和 FVIII 和 FIX 高于 0.01 IU/mL 时,FXIa 升高了 TG/CFL。FXIa 仅在低 FV 和 FVII 时影响 PG。在高因子浓度下,FXIa 降低了 MCD。凝血酶和纤溶酶底物对 CT、LyT、LiT 和 MCD 参数有影响。
FXIa 揭示了因子缺乏症中 TG、PG 和 CFL 参数之间的新关系,这表明其在鉴别出血表型方面具有潜在的益处。